Tag: Coronavirus Research

Shiv Nadar University claims to have developed a molecule with potential to cure COVID-19

Shiv Nadar University, India’s multidisciplinary and research-based university, announced a potential breakthrough solution in the global battle against COVID-19.  “A team of researchers led by Dr Subhabrata Sen from the Department of Chemistry, Shiv Nadar University, India along with his collaborator Professor Ralf Jockers, Institut Cochin (INSERM, CNRS, Université de Paris, France), has discovered a…

J&J announces a lead vaccine candidate for Covid-19

Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; and the rapid scaling of the company’s manufacturing capacity with the goal of providing global supply of more than one billion doses of a vaccine.  The company expects to initiate human clinical studies…

Frankfurt-headquartered Innoplexus announces major findings in potential combination therapies for Covid-19

Innoplexus AG announced some first results in its artificial intelligence enabled search for a COVID-19 antiviral treatment. Innoplexus began by scanning data on previously approved drugs for off-label potential in treating COVID-19, using its proprietary artificial intelligence (AI) and big data platform to generate actionable insights from hundreds of terabytes of structured and unstructured public…

Amazon to deliver COVID-19 at-home test kits in Seattle

Amazon Care, the medical care arm for Amazon’s employees, has recently partnered with Bill Gates-backed research program SCAN to pick up and deliver at-home coronavirus test kits in Seattle. As reported first by CNBC, Amazon is going to be working with Seattle Coronavirus Assessment Network, or SCAN, a new research initiative backed in part by…

Coronavirus: S&P Global makes Covid-19 research, reports, data & analysis freely available to the public

S&P Global, the world’s foremost provider of credit ratings, benchmarks and analytics in the global capital and commodity markets, announced that it is providing complimentary research, reports, analytics, and data pertaining to the Novel Coronavirus Disease (COVID-19) outbreak to the public. The Company has introduced a special website containing original, exclusive and curated research content…